Sodium-Glucose Cotransporter 2 Inhibitors Improve Chronic Diabetic Macular Edema
Purpose. Diabetic macular edema (DME) is a vision-threatening condition that develops in diabetic patients. The first-line therapy for DME is intravitreal injections of antivascular endothelial growth factor (anti-VEGF) agents; however, the high frequency of repeat injections, invasiveness of the pr...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
Wiley
2020-01-01
|
| Серія: | Case Reports in Ophthalmological Medicine |
| Онлайн доступ: | http://dx.doi.org/10.1155/2020/8867079 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|